Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.58B | 1.55B | 1.43B | 1.25B | 1.03B | 666.20M |
Gross Profit | 732.20M | 772.70M | 493.70M | 611.90M | 495.40M | 321.60M |
EBITDA | 222.70M | 222.20M | 197.40M | 183.40M | 75.10M | 99.70M |
Net Income | -57.90M | -59.40M | -85.60M | -16.60M | -160.40M | -157.10M |
Balance Sheet | ||||||
Total Assets | 3.41B | 3.38B | 3.29B | 3.38B | 2.84B | 2.57B |
Cash, Cash Equivalents and Short-Term Investments | 57.90M | 79.50M | 39.00M | 110.50M | 141.80M | 101.50M |
Total Debt | 1.38B | 1.37B | 1.35B | 1.37B | 1.15B | 1.65B |
Total Liabilities | 1.64B | 1.61B | 1.55B | 1.59B | 1.32B | 1.99B |
Stockholders Equity | 1.77B | 1.77B | 1.74B | 1.79B | 1.51B | 584.00M |
Cash Flow | ||||||
Free Cash Flow | 147.70M | 147.10M | 123.80M | 106.00M | 36.80M | -52.40M |
Operating Cash Flow | 199.80M | 194.20M | 153.40M | 138.60M | 55.10M | -35.20M |
Investing Cash Flow | -214.50M | -170.80M | -172.10M | -419.80M | -262.90M | -151.30M |
Financing Cash Flow | 19.20M | 16.50M | -52.30M | 247.50M | 248.10M | 202.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | C$1.15B | 15.05 | 71.61% | 3.68% | 9.38% | 117.85% | |
71 Outperform | C$1.72B | 44.09 | 6.93% | 4.99% | 8.76% | 14.05% | |
67 Neutral | C$1.08B | 30.45 | -3.53% | ― | 17.19% | -191.01% | |
63 Neutral | C$1.64B | ― | -3.31% | 0.30% | 9.88% | 11.07% | |
61 Neutral | C$185.10M | ― | -4.48% | ― | -0.69% | 8.08% | |
46 Neutral | C$194.28M | -4.22 | -8.60% | 2.64% | 13.54% | -1.44% | |
$231.40M | 2.54 | 33.87% | 2.15% | ― | ― |
Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, has declared a dividend of $0.025 per share, payable on July 22, 2025, to shareholders of record as of July 3, 2025. The company also announced that it will release its second-quarter 2025 financial results on August 8, 2025, followed by a conference call to provide a business update, which may influence stakeholder perceptions and market positioning.
The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings Ltd., a leading network of dental practices in Canada and North America, announced its participation in upcoming investor conferences, including the Jefferies Global Healthcare Conference and Canaccord Genuity’s Annual Growth Conference. This participation underscores Dentalcorp’s commitment to engaging with investors and stakeholders, potentially enhancing its industry positioning and growth prospects.
The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings announced the results of its Annual General and Special Meeting of Shareholders, where all nominated directors were elected, Ernst & Young LLP was re-appointed as auditors, and amendments to the company’s Equity Incentive Plan, Legacy Option Plan, and Deferred Share Unit were approved. These decisions reflect the company’s strategic focus on strengthening its governance and operational framework, potentially enhancing its position in the dental industry and providing growth opportunities for stakeholders.
The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.00 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings reported robust financial results for the first quarter of 2025, with a 9.9% increase in revenue to $409.4 million and a 11.5% rise in Adjusted EBITDA to $75.9 million. The company expanded its national footprint by acquiring 12 new practice locations and achieved a 91.5% recurring patient visit rate, reflecting strong demand and patient loyalty. Looking ahead, Dentalcorp anticipates continued growth in the second quarter, with expected revenue increases of 9.0% to 10.0% and further Adjusted EBITDA margin expansion.
The most recent analyst rating on (TSE:DNTL) stock is a Buy with a C$11.0000 price target. To see the full list of analyst forecasts on dentalcorp Holdings stock, see the TSE:DNTL Stock Forecast page.
Dentalcorp Holdings Ltd. announced it will hold its Annual General and Special Meeting of Shareholders on May 22, 2025, in a virtual-only format to ensure equal participation opportunities for shareholders regardless of location. This meeting is significant for stakeholders as it reflects Dentalcorp’s commitment to transparency and inclusivity, potentially strengthening its position in the dental industry by fostering trust and engagement with its shareholders.